Series A · Biotech · Paris, France · Founded 2024 · 11–50 employees
Bioptimus is a Paris-based biotech AI company developing universal AI foundation models to transform biology by integrating multi-modal, multi-scale biological data, aiming to accelerate scientific breakthroughs and innovations in biomedical and environmental sciences; founded in 2024 by ex-Google DeepMind and Owkin scientists, it has raised a total of $76 million, including a $41 million Series A round in January 2025, to advance its mission.
No open roles listed right now.